DK1791571T3 - Radiofluorinerede peptider - Google Patents

Radiofluorinerede peptider

Info

Publication number
DK1791571T3
DK1791571T3 DK05790076T DK05790076T DK1791571T3 DK 1791571 T3 DK1791571 T3 DK 1791571T3 DK 05790076 T DK05790076 T DK 05790076T DK 05790076 T DK05790076 T DK 05790076T DK 1791571 T3 DK1791571 T3 DK 1791571T3
Authority
DK
Denmark
Prior art keywords
radiofluorinated
peptides
processes
radiopharmaceuticals
iiia
Prior art date
Application number
DK05790076T
Other languages
English (en)
Inventor
Magne Solbakken
Bente Arbo
Alan Cuthbertson
Alexander Gibson
Original Assignee
Ge Healthcare As
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As, Ge Healthcare Ltd filed Critical Ge Healthcare As
Application granted granted Critical
Publication of DK1791571T3 publication Critical patent/DK1791571T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK05790076T 2004-09-14 2005-09-14 Radiofluorinerede peptider DK1791571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
DK1791571T3 true DK1791571T3 (da) 2008-12-08

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05790076T DK1791571T3 (da) 2004-09-14 2005-09-14 Radiofluorinerede peptider

Country Status (24)

Country Link
US (2) US7875701B2 (da)
EP (1) EP1791571B1 (da)
JP (1) JP4949251B2 (da)
KR (1) KR101243016B1 (da)
CN (1) CN101151054B (da)
AT (1) ATE404225T1 (da)
AU (1) AU2005283904B8 (da)
BR (1) BRPI0515175A (da)
CA (1) CA2578470C (da)
DE (1) DE602005008996D1 (da)
DK (1) DK1791571T3 (da)
ES (1) ES2312018T3 (da)
GB (1) GB0420344D0 (da)
HK (1) HK1118713A1 (da)
IL (1) IL181529A (da)
MX (1) MX2007003019A (da)
NO (1) NO20071880L (da)
NZ (1) NZ553384A (da)
PL (1) PL1791571T3 (da)
PT (1) PT1791571E (da)
RU (1) RU2396272C9 (da)
SI (1) SI1791571T1 (da)
WO (1) WO2006030291A2 (da)
ZA (1) ZA200702700B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100932827B1 (ko) * 2001-07-10 2009-12-21 지이 헬스케어 에이에스 펩티드계 화합물
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
MX2009002775A (es) 2006-09-15 2009-06-17 Siemens Medical Solutions Derivados de ciclopeptido de quimica click como agentes de formacion de imagen para integrinas.
WO2008072976A2 (en) * 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
US8241606B2 (en) 2006-12-18 2012-08-14 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
WO2008083191A2 (en) * 2006-12-28 2008-07-10 Ge Healthcare As Radiofluorination methods
MX2009009291A (es) * 2007-03-01 2009-12-14 Bayer Schering Pharma Ag Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
CN101854957B (zh) * 2007-09-10 2013-05-22 通用电气健康护理有限公司 放射性氟化方法
JP5399422B2 (ja) * 2008-02-28 2014-01-29 ジーイー・ヘルスケア・リミテッド 市販の安価な化学薬品からのｐｅｇ−６成分の合成
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
US20120229804A1 (en) 2009-12-21 2012-09-13 Medi-Physics, Inc. Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f- ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
MX2013006202A (es) 2010-12-01 2013-07-29 Ge Healthcare Ltd Metodo de radioconjugacion.
KR20130124522A (ko) * 2010-12-09 2013-11-14 지이 헬쓰케어 리미티드 방사성 추적자 조성물
WO2012087725A1 (en) * 2010-12-21 2012-06-28 Ge Healthcare Limited Use of aniline iν the radiostabilization of oxime ligation
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN106999603B (zh) 2014-12-04 2022-05-27 通用电气健康护理有限公司 从放射性药物中除去乙醛的方法
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100932827B1 (ko) * 2001-07-10 2009-12-21 지이 헬스케어 에이에스 펩티드계 화합물
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
CN101151054A (zh) 2008-03-26
WO2006030291A2 (en) 2006-03-23
US8563600B2 (en) 2013-10-22
ES2312018T3 (es) 2009-02-16
KR101243016B1 (ko) 2013-03-12
RU2396272C2 (ru) 2010-08-10
NO20071880L (no) 2007-06-13
US20110117016A1 (en) 2011-05-19
BRPI0515175A (pt) 2008-07-08
JP4949251B2 (ja) 2012-06-06
AU2005283904B2 (en) 2012-01-19
MX2007003019A (es) 2007-08-07
KR20070053750A (ko) 2007-05-25
RU2007108762A (ru) 2008-10-27
AU2005283904B8 (en) 2012-02-23
CA2578470C (en) 2015-09-01
IL181529A (en) 2015-04-30
US20080095701A1 (en) 2008-04-24
SI1791571T1 (sl) 2009-02-28
AU2005283904A1 (en) 2006-03-23
CA2578470A1 (en) 2006-03-23
ATE404225T1 (de) 2008-08-15
ZA200702700B (en) 2008-09-25
PT1791571E (pt) 2008-11-19
JP2008516894A (ja) 2008-05-22
US7875701B2 (en) 2011-01-25
GB0420344D0 (en) 2004-10-13
EP1791571B1 (en) 2008-08-13
IL181529A0 (en) 2007-07-04
HK1118713A1 (en) 2009-02-20
NZ553384A (en) 2011-02-25
PL1791571T3 (pl) 2009-01-30
CN101151054B (zh) 2014-09-24
EP1791571A2 (en) 2007-06-06
DE602005008996D1 (de) 2008-09-25
WO2006030291A3 (en) 2007-06-14
RU2396272C9 (ru) 2010-12-10

Similar Documents

Publication Publication Date Title
DK1791571T3 (da) Radiofluorinerede peptider
SE0301653D0 (sv) Novel compounds
EA201070786A1 (ru) Бензофуропиримидиноны
EA201000844A1 (ru) Связывающие wise агенты и эпитопы
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
ECSP13012436A (es) ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
CY1112653T1 (el) Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
MA33208B1 (fr) Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20092611L (no) Krystallinsk faststoff Rasagilin base
CR10157A (es) Compuestos químicos
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
EA200702352A1 (ru) Новые композиции нутрицевтиков
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
EA200801414A1 (ru) Кальцилитические соединения
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
CY1110891T1 (el) Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
WO2009035959A3 (en) Radiofluorination methods
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
NO20091386L (no) Fenyloksyanilinderivater